The US Food and Drug Administration (FDA) has approved the use of an antiviral drug, remidesivir, to treat patients with coronavirus.
According to US regulators, coronavirus patients have been allowed to use remediation based on the results of clinical trials.
Clinical trials have shown that the drug’s use has reduced patients’ recovery time to an average of five days. Only in the United States has remedicavir been allowed for emergency use since May.
US President Trump, who suffered from corona, was also given the drug during treatment.